MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Protein Degradation and Inhibitors
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

818 results · 1 filter active ·
Results by year
20022025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
818 works in the cohort · of 4,299,418page 2 of 17

Labels cover 1 of 818 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 818 of 818 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
Target 2035: probing the human proteome
Adrian J. Carter, Oliver Kraemer, Matthias Zwick, Anke Mueller‐Fahrnow, C.H. Arrowsmith, A.M. Edwards
2019· article· en· Drug Discovery Today· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
178
citations
fundno affno abstractunlabeled
Beating the odds: BETs in disease
Chenyi Wang, P. Filippakopoulos
2015· review· en· Trends in Biochemical Sciences· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
148
citations
fundno affno abstractunlabeled
Targeted protein degradation for cancer therapy
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, Georg E. Winter
2025· review· en· Nature reviews. Cancer· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
138
citations
affno abstractunlabeled
Functional interdependence of BRD4 and DOT1L in MLL leukemia
Omer Gilan, Enid Y.N. Lam, Isabelle Becher, Dave Lugo, Ester Cannizzaro, Gérard Joberty +25 more
2016· article· en· Nature Structural & Molecular Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
124
citations
fundno affno abstractunlabeled
Identifying druggable disease-modifying gene products
Scott J. Dixon, Brent R. Stockwell
2009· review· en· Current Opinion in Chemical Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
120
citations
affno abstractunlabeled
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
Jark Böttcher, David Dilworth, Ulrich Reiser, Ralph A. Neumüller, Michael Schleicher, Mark Petronczki +37 more
2019· article· en· Nature Chemical Biology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
103
citations

How this was built: Screen · Findings · About